title: Rediscovery of nefopam for the treatment of neuropathic pain.
abstract: Nefopam (NFP) is a non-opioid, non-steroidal, centrally acting analgesic drug that is derivative of the non-sedative benzoxazocine, developed and known in 1960s as fenazocine. Although the mechanisms of analgesic action of NFP are not well understood, they are similar to those of triple neurotransmitter (serotonin, norepinephrine, and dopamine) reuptake inhibitors and anticonvulsants. It has been used mainly as an analgesic drug for nociceptive pain, as well as a treatment for the prevention of postoperative shivering and hiccups. Based on NFP's mechanisms of analgesic action, it is more suitable for the treatment of neuropathic pain. Intravenous administration of NFP should be given in single doses of 20 mg slowly over 15-20 min or with continuous infusion of 60-120 mg/d to minimize adverse effects, such as nausea, cold sweating, dizziness, tachycardia, or drowsiness. The usual dose of oral administration is three to six times per day totaling 90-180 mg. The ceiling effect of its analgesia is uncertain depending on the mechanism of pain relief. In conclusion, the recently discovered dual analgesic mechanisms of action, namely, a) descending pain modulation by triple neurotransmitter reuptake inhibition similar to antidepressants, and b) inhibition of long-term potentiation mediated by NMDA from the inhibition of calcium influx like gabapentinoid anticonvulsants or blockade of voltage-sensitive sodium channels like carbamazepine, enable NFP to be used as a therapeutic agent to treat neuropathic pain.
authors.affiliation: Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Korea.
authors.forename: Kyung Hoon
authors.initials: KH
authors.lastname: Kim
authors.affiliation: Department of Pain Medicine, Division of Anesthesiology and Critical Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Salahadin
authors.initials: S
authors.lastname: Abdi
keywords: adverse drug reactions; molecular mechanisms of pharmacological action; nefopam; neuropathic pain; nonopioid analgesics
references.citation: Anaesthesia. 1994 Dec;49(12):1046-9
references.pmid: 7864317
references.citation: Curr Ther Res Clin Exp. 1974 Jun;16(6):602-8
references.pmid: 4211140
references.citation: Reg Anesth Pain Med. 2005 Sep-Oct;30(5):417-21
references.pmid: 16135344
references.citation: Curr Ther Res Clin Exp. 1974 Jun;16(6):609-16
references.pmid: 4211141
references.citation: Brain Res. 2004 Jul 9;1013(2):249-55
references.pmid: 15193535
references.citation: Chirality. 2000 Mar;12(3):153-9
references.pmid: 10689295
references.citation: Anesth Analg. 2001 Nov;93(5):1358-60
references.pmid: 11682430
references.citation: Anesthesiology. 2004 Jan;100(1):37-43
references.pmid: 14695722
references.citation: Epilepsy Res. 2006 Jun;69(3):183-272
references.pmid: 16835945
references.citation: Pain. 1987 Jul;30(1):103-114
references.pmid: 3614974
references.citation: Neuroscience. 2012 Jun 1;211:39-50
references.pmid: 22244975
references.citation: Acta Anaesthesiol Scand. 1979 Dec;23(6):555-60
references.pmid: 397711
references.citation: N Engl J Med. 2000 Dec 28;343(26):1973-4
references.pmid: 11186682
references.citation: Br J Pharmacol. 1969 Sep;37(1):69-78
references.pmid: 5343358
references.citation: Fundam Clin Pharmacol. 2007 Oct;21(5):555-8
references.pmid: 17868209
references.citation: Ann N Y Acad Sci. 1989;575:171-91; discussion 192-3
references.pmid: 2699187
references.citation: J Neurotrauma. 2003 Jun;20(6):593-601
references.pmid: 12906743
references.citation: Anesth Analg. 2009 Aug;109(2):623-31
references.pmid: 19608840
references.citation: Curr Ther Res Clin Exp. 1975 Jun;17(6):519-24
references.pmid: 808373
references.citation: Crit Care Med. 2012 Nov;40(11):3070-82
references.pmid: 22890247
references.citation: Amino Acids. 2005 Mar;28(2):183-91
references.pmid: 15714253
references.citation: Korean J Anesthesiol. 2013 Mar;64(3):229-33
references.pmid: 23560188
references.citation: Arch Neurol. 2004 May;61(5):641-4
references.pmid: 15148138
references.citation: Fundam Clin Pharmacol. 2011 Feb;25(1):1-28
references.pmid: 20030738
references.citation: Neuropharmacology. 1999 Aug;38(8):1083-152
references.pmid: 10462127
references.citation: Nat Rev Neurosci. 2003 Jan;4(1):13-25
references.pmid: 12511858
references.citation: Curr Drug Targets. 2012 Jan;13(1):15-27
references.pmid: 21777184
references.citation: Br J Anaesth. 2007 Nov;99(5):748-9
references.pmid: 17933805
references.citation: Clin Pharmacol Ther. 1975 Aug;18(2):175-9
references.pmid: 1097153
references.citation: Korean J Pain. 2013 Jan;26(1):14-20
references.pmid: 23342202
references.citation: Pharmacol Res. 2001 Dec;44(6):541-5
references.pmid: 11735363
references.citation: J Clin Pharmacol New Drugs. 1972 May-Jun;12(5):230-8
references.pmid: 4555883
references.citation: Pharmacol Rep. 2011;63(3):690-6
references.pmid: 21857079
references.citation: Amino Acids. 2007;32(3):323-32
references.pmid: 17021653
references.citation: Neurotherapeutics. 2009 Oct;6(4):703-12
references.pmid: 19789074
references.citation: Pharmacol Rev. 2007 Dec;59(4):360-417
references.pmid: 18160701
references.citation: Cochrane Database Syst Rev. 2011 Sep 07;(9):CD008659
references.pmid: 21901726
references.citation: Drugs. 2007;67(15):2121-33
references.pmid: 17927280
references.citation: Drugs. 1980 Apr;19(4):249-67
references.pmid: 6991238
references.citation: Xenobiotica. 1974 Jun;4(6):355-63
references.pmid: 4842015
references.citation: Minerva Anestesiol. 1991 Sep;57(9):760-2
references.pmid: 1798568
references.citation: J Pharmacol Exp Ther. 1976 Dec;199(3):649-61
references.pmid: 994022
references.citation: Eur J Pharmacol. 2002 Apr 19;441(1-2):67-74
references.pmid: 12007921
references.citation: Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11178-83
references.pmid: 22711801
references.citation: Cochrane Database Syst Rev. 2009 Jul 08;(3):CD007442
references.pmid: 19588431
references.citation: Curr Ther Res Clin Exp. 1974 Mar;16(3):184-93
references.pmid: 4206725
references.citation: Br J Anaesth. 2008 Nov;101(5):610-7
references.pmid: 18796441
references.citation: Br J Anaesth. 2012 May;108(5):784-91
references.pmid: 22331396
references.citation: Pharmacol Rev. 1994 Jun;46(2):157-203
references.pmid: 7938165